Overdose Deaths Are Falling. The Craving Didn't Get the Memo.

Lisa was in her thirties, in southern Wyoming, dreading a custody hearing over her daughter, when she picked up fentanyl for the first time. She told Cowboy State Daily it wasn’t a high she was chasing. It was the dread. “It’s insane,” she said. “The thing that was wrecking me was the only thing I trusted to make the pain stop.” Weeks later she overdosed before another court date and woke up in a hospital with a naloxone drip in her arm, after a deputy did compressions and reversed the overdose on the floor of the courthouse.

A national chart says this shouldn’t be happening as much anymore. CDC provisional data shows overdose deaths down roughly 12% for the year ending in early 2026, on top of a record 26.2% drop from 2023 to 2024 reported in the agency’s most recent data brief. That’s real, and it’s the best overdose news the country has had in a decade.

A falling national death rate says nothing about whether the disease inside any one person got easier to carry.

That’s the part the press releases skip. Lisa’s overdose happened this month, inside a decline that’s supposedly sparing people like her. Wyoming logged about 350 opioid-related overdose deaths from 2020 through 2024, more than 90% unintentional, with Sweetwater County running close to 29 deaths per 100,000 residents — among the worst rates in a state that barely registers in national fentanyl coverage next to Ohio, West Virginia, or Philadelphia. The numbers are dropping in the aggregate. They are not dropping evenly, and they are not dropping because craving got weaker.

What’s actually happening in the brain, not just the news

If you’ve used opioids long enough to feel sick without them, you already know the thing doctors take years to explain to each other: at some point you stop using to feel good and start using so you don’t feel unbearable. That’s not a metaphor and it’s not weakness. Researchers call it negative reinforcement — using a drug not to chase a reward but to shut off a state of dread, nausea, and skin-crawling wrongness that the drug itself created. A 2021 review in Science Advances on withdrawal-conditioned cues argues this mechanism gets neglected in a field obsessed with the initial high, even though it’s what actually drives relapse months and years down the line. Lisa’s own words map onto the research almost exactly: “It’s one of those things that you have to have it in order not to be sick.”

Here’s the part that catches people off guard, including plenty of clinicians: craving for opioids doesn’t reliably fade the longer you’re away from them — it can intensify. Scientists call this incubation of craving, and a PNAS study published this year mapped brain-wide connectivity changes during abstinence that predicted exactly this pattern — the drug-seeking urge growing, not shrinking, over the weeks after stopping. That study was done in rats, and translating any animal finding straight onto human experience is a mistake researchers themselves warn against. But it lines up with what people in early recovery report constantly: months three and four feeling worse than week one, not better. Add the low mood, flattened pleasure, and short fuse of protracted withdrawal — a stretch that can run anywhere from a few months to closer to a year — and you get a period where a person is furthest from a needle in calendar time and closest to it in urge. If nobody warns you that’s coming, you read it as proof recovery isn’t working instead of a predictable, survivable phase with a name.

None of this is a character problem. It’s what a brain does after fentanyl has spent months rewriting its reward circuitry and its stress response at the same time. You are not weak for still wanting it. You are having a documented, studied, entirely typical reaction to a drug built to produce exactly this reaction.

You are having a documented, studied, entirely typical reaction to a drug built to produce exactly this reaction.

Wyoming’s overdose wasn’t just Lisa’s failure

Wyoming’s fentanyl numbers aren’t an accident of geography, either. When states raced to pass naloxone access laws between 2012 and 2015 — allowing pharmacists to hand the overdose-reversal drug to family members, bystanders, and outreach workers without an individual prescription — Wyoming was one of only seven states still holding out, according to a Network for Public Health Law history of the policy’s rapid national spread. That fight wasn’t abstract. Slower access meant fewer kits in fewer hands in exactly the rural counties where an ambulance is forty-five minutes out. By the time Lisa overdosed in a Wyoming courthouse this month, a deputy carrying naloxone was standard enough to save her — but that standard took a full decade longer to reach her state than it took to reach a Baltimore or a Boston, and every year of that gap has a body count attached to it that nobody totaled up state by state.

The one thing that’s still real tonight

The genuinely good news buried under all this: naloxone is still free, still funded, and still expanding, not shrinking. States have committed a share of the roughly $57.7 billion in national opioid settlement money specifically to naloxone distribution, and programs from Wyoming to Wisconsin are mailing kits at no cost to anyone who asks. Fentanyl is still cut into supply everywhere, including a batch that could be the one — Indiana’s coroners are still calling it the driver of roughly 62% of overdose deaths in their state even as the national line trends down. Carrying naloxone isn’t a statement about whether you’re “serious” about recovery. It’s a hedge against a supply nobody controls, purchased for you already by a settlement you didn’t have to fight for.

Lisa is not a statistic that moved a percentage point. She’s a person who used a drug to survive a courtroom and nearly died on the floor of one, and who is telling a reporter about it now instead of showing up in next year’s data brief. The national curve bending down is real, and it is not going to be the thing that gets any one specific person through the next craving at 2 a.m. That’s still going to take a phone number, a kit in a bag, and someone who picks up. Keep all three close, especially on the week the headlines tell you things are getting better.